World Health Organisation’s (WHO) work on infertility
24. September, 2020.
Share post:
Reading time: min
Klaudija Kordic
FE new representative to Infertility GDG
Klaudija Kordic, Vice-Chair of Fertility Europe and RODA, Croatia representative became our new WHO Infertility Guideline Development Group representative. Anna Krawczak (Nasz Bocian, Poland) was working and doing great job with the group since 2016 and now decided to pass this task on.
The group consists of experienced healthcare professionals and patients activists from all over the world and we are looking forward to see more results of their work, which should be definitive in creating guidelines for safe, equal and efficient fertility treatments and widely available fertility education.
WHO Infertility fact sheet
14 September 2020 the WHO published a fact sheet about infertility summarising the main information and issues. See the Key facts from the document below:
Infertility is a disease of the male or female reproductive system defined by the failure to achieve a pregnancy after 12 months or more of regular unprotected sexual intercourse.(1)
Infertility affects millions of people of reproductive age worldwide – and has an impact on their families and communities. Estimates suggest that between 48 million couples and 186 million individuals live with infertility globally. (2, 3, 4)
In the male reproductive system, infertility is most commonly caused by problems in the ejection of semen (1), absence or low levels of sperm, or abnormal shape (morphology) and movement (motility) of the sperm.
In the female reproductive system, infertility may be caused by a range of abnormalities of the ovaries, uterus, fallopian tubes, and the endocrine system, among others.
Infertility can be primary or secondary. Primary infertility is when a pregnancy has never been achieved by a person, and secondary infertility is when at least one prior pregnancy has been achieved.
Fertility care encompasses the prevention, diagnosis and treatment of infertility. Equal and equitable access to fertility care remains a challenge in most countries; particularly in low and middle-income countries. Fertility care is rarely prioritized in national universal health coverage benefit packages.
Join our newsletter to receive heartfelt stories, expert insights, and updates from Fertility Europe.
Be the first to know about our advocacy efforts and community events
Discover ways your support makes an impact
Hear directly from those whose lives you’re changin
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
